HoYAG vs TFL in miniPCNL With ClearPetra (NCT07087977) | Clinical Trial Compass
RecruitingNot Applicable
HoYAG vs TFL in miniPCNL With ClearPetra
United States150 participantsStarted 2025-08-22
Plain-language summary
Mini percutaneous nephrolithotripsy is the treatment of choice for kidney stones over 2cm. This procedure commonly uses laser energy for breaking the stones, and among possible laser platforms, Hoyag and thulium fiber laser are FDA approved. Recently, this procedure has also included the use of vacuum assisted renal access sheaths, which allows suction to be employed together with the breaking of stones. This study intends to compare outcomes when using either laser platforms with suction sheaths in participants undergoing mini percutaneous nephrolithotripsy for the treatment of kidney stones.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Males or females over 18 years of age
✓. Patients with kidney stones, with stone burden larger than 15 mm.
✓. Patients undergoing new percutaneous access with primary, supine, unilateral mini-PCNL.
Exclusion criteria
✕. Simultaneous use of more than 1 laser platform or other form of fragmentation (e.g., ultrasonic).
✕. Patients undergoing simultaneous treatment of contralateral kidney stones during the same procedure.
✕. Patients undergoing simultaneous treatment of ureteral stones during the same procedure.
✕. Pregnant patients.
✕. Presence of genitourinary anatomical abnormalities.